(R)-(-)-10-Methyl-11-hydroxyaporphine: A Highly Selective Serotonergic Agonist

Journal of Medicinal Chemistry

Volumn 31, Issue 2, 1988, Pages 313-318

  Cannon, Joseph G ^a   Mohan, Prem ^a   Bojarski, Jacek ^a   Long, John Paul ^a   Bhatnagar, Ranbir K ^a   Leonard, Paul A ^a   Flynn, Jan R ^a   Chatterjee, Tapan K ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11 HYDROXY 10 METHYLAPORPHINE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; DOPAMINE RECEPTOR; SEROTONIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BIOLOGICAL MODEL; BRAIN REGION; CAT; DRUG RECEPTOR BINDING; NONHUMAN; RAT; SEROTONIN METABOLISM; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0006466746     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm00397a007     Document Type: Article

References (24)

1. Cannon, J. G.; Koble, D. L.; Long, J. P.; Verimer, T. J. Med. Chem. 1980, 23, 750.
2. Verimer, T.; Long, J. P.; Bhatnagar, R. K.; Koble, D. L.; Cannon, J. G.; Flynn, J. R.; Goodale, D. B.; Arneric, S. P. Arch. Intern. Pharmacodyn. Ther. 1981, 250, 221.
3. Cannon, J. G.; Furlano, D. C.; Koble, D. L.; Koons, J. C.; Long, J. P. Life Sci. 1984, 34, 1679.
4. Cannon, J. G.; Furlano, D. C.; Dushin, R. G.; Chang, Y.-A.; Baird, S. R.; Soliman, L. N.; Flynn, J. R.; Long, J. P.; Bhatnagar, R. K. J. Med. Chem. 1986, 29, 2016.
5. Cannon, J. G. Prog. Drug Res. 1985, 29, 303 and references cited therein.
6. Ram, V. J.; Neumeyer, J. L. J. L. J. Org. Chem. 1982, 47, 4372.
7. Hussey, B. J.; Johnstone, R. A. W.; Entwistle, I. D. Tetrahedron 1982, 38, 3775.
8. Entwistle, I. D.; Hussey, B. J.; Johnstone, R. A. W. Tetrahedron Lett. 1980, 21, 4747.
9. Casiraghi, G.; Casnati, G.; Cornia, M.; Pochini, A.; Puglia, G.; Sartori, G.; Ungaro, P. J. Chem. Soc., Perkin Trans. 1 1978, 318.
10. Casiraghi, G.; Casnati, G.; Puglia, G.; Sartori, G.; Jerenghi, G. J. Chem. Soc., Perkin Trans. 1 1980, 1862.
11. Ilhan, M.; Long, J. P.; Cannon, J. G. Arch. Int. Pharmacodyn. Ther. 1974, 212, 247.
12. Ilhan, M.; Long, J. P. Arch. Int. Pharmacodyn. Ther. 1975, 216, 4.
13. Maixner, W.; Flynn, J. R.; Arneric, S. P.; Cannon, J. G.; Long, J. P. J. Pharmacol. Exp. Ther. 1983, 224, 352.
14. Ilhan, M.; Long, J. P.; Cannon, J. G. Arch. Int. Pharmacodyn. Ther. 1976, 219, 193.
15. Arvidsson, L.-E.; Hacksell, U.; Nilsson, J. L. G.; Hjorth, S.; Carlsson, A.; Lindberg, P.; Sanchez, D.; Wilkstrom, H. J. Med. Chem. 1981, 24, 921.
16. Arvidsson, L.-E.; Hacksell, U.; Johansson, A. M.; Nilsson, J. L. G.; Lindberg, P.; Sanchez, D.; Wikstrom, H. J. Med. Chem. 1984, 27, 45.
17. Modigh, K. J. Pharm. Pharmacol. 1973, 25, 926.
18. Néckers, L. M.; Neff, N. H.; Wyatt, R. J. Naunyn-Schmiedeberg's Arch. Pharmacol. 1979, 306, 173.
19. Middlemiss, D. N.; Fozard, J. R. Eur. J. Pharmacol. 1983, 90, 151.
20. van de Waterbeemd, H.; Carrupt, P.-A.; Testa, B. Helv. Chim. Acta 1985, 68, 715.
21. Peroutka, S. J.; Snyder, S. H. Mol. Pharmacol. 1979, 16, 687.
22. Munson, P. J.; Robard, D. Anal. Biochem. 1980, 107, 220.
23. Nielsen, J. A.; Johnston, C. A. Life Sci. 1982, 31, 2847.
24. Mefford, I. N.; Jurik, S. M.; Noyce, N.; Barchas, J. D. In Methods of Biogenic Amine Research; Parvez, S., Nagatsu, T., Nagatsu, I., Parvez, H., Eds.; Elsevier: New York, 1983; pp 101-110.